Comments
Loading...
Calidi Biotherapeutics (CLDI) Forecast
NewsEarningsCalidi Biotherapeutics (CLDI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCalidi Biotherapeutics (AMEX:CLDI) Stock Quotes, Forecast and News Summary
Calidi Biotherapeutics Stock (AMEX: CLDI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Calidi Biotherapeutics (CLDI) stock?
You can purchase shares of Calidi Biotherapeutics (AMEX:CLDI) through any online brokerage.
Who are Calidi Biotherapeutics (CLDI) competitors?
Other companies in Calidi Biotherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Curis (NASDAQ:CRIS) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for Calidi Biotherapeutics (CLDI) stock?
Calidi Biotherapeutics has a consensus price target of $1.67.
What is the current price for Calidi Biotherapeutics (CLDI)?
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $2.1401 last updated November 21, 2024 at 9:53 AM EST.
Does Calidi Biotherapeutics (CLDI) pay a dividend?
There are no upcoming dividends for Calidi Biotherapeutics.
When is Calidi Biotherapeutics (AMEX:CLDI) reporting earnings?
Calidi Biotherapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Calidi Biotherapeutics (CLDI) going to split?
There is no upcoming split for Calidi Biotherapeutics.
What sector and industry does Calidi Biotherapeutics (CLDI) operate in?
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.